Pulsed Laser Light and Nano-encapsulated Ocular Dyes for Advanced Therapies in the Eye

01 September 2023 → 31 August 2028
European funding: framework programme
Principal investigator
Research disciplines
  • Medical and health sciences
    • Pharmaceutical technology
sight loss
Other information
Project description

Vision impairment is a major cause of disability. In Europe, an average of 1 in 30 people experience sight loss. Treatment of ocular diseases is a top priority today. However, the arsenal of medications remains rather restricted to traditional drugs despite improvements in pharmacological treatments. In this context, the EU-funded DYE-LIGHT project will explore new ways to deliver biotherapeutics and perform ocular surgery. Going beyond current methods that include eye drops and injections, the project will consider the use of pulsed lasers at much lower energy levels than currently used in ocular surgery in combination with nanoencapsulated vital dyes used by surgeons to stain tissues.

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Council Executive Agency (ERCEA). Neither the European Union nor the authority can be held responsible for them.